These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 11411800)
21. Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A. Gessa GL; Mascia MS; Casu MA; Carta G Eur J Pharmacol; 1997 May; 327(1):R1-2. PubMed ID: 9185841 [TBL] [Abstract][Full Text] [Related]
22. Effects of cannabinoid agonists on sheep sphincter of oddi in vitro. Sarac B; Durmus N; Altun A; Turan M; Kaya T; Sencan M; Bagcivan I Pancreatology; 2011; 11(4):428-33. PubMed ID: 21921665 [TBL] [Abstract][Full Text] [Related]
23. Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in guinea-pig vessels, but not in rat and mouse aorta. Schultheiss T; Flau K; Kathmann M; Göthert M; Schlicker E Naunyn Schmiedebergs Arch Pharmacol; 2005 Aug; 372(2):139-46. PubMed ID: 16195872 [TBL] [Abstract][Full Text] [Related]
24. The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2. Darmani NA Eur J Pharmacol; 2001 Oct; 430(1):49-58. PubMed ID: 11698062 [TBL] [Abstract][Full Text] [Related]
25. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids. Janoyan JJ; Crim JL; Darmani NA Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518 [TBL] [Abstract][Full Text] [Related]
26. Intravenous self-administration of the cannabinoid CB1 receptor agonist WIN 55,212-2 in rats. Fattore L; Cossu G; Martellotta CM; Fratta W Psychopharmacology (Berl); 2001 Aug; 156(4):410-6. PubMed ID: 11498718 [TBL] [Abstract][Full Text] [Related]
27. Involvement of cannabinoid receptors in inflammatory hypersensitivity to colonic distension in rats. Sanson M; Bueno L; Fioramonti J Neurogastroenterol Motil; 2006 Oct; 18(10):949-56. PubMed ID: 16961698 [TBL] [Abstract][Full Text] [Related]
28. Analgesic, respiratory and heart rate effects of cannabinoid and opioid agonists in rhesus monkeys: antagonist effects of SR 141716A. Vivian JA; Kishioka S; Butelman ER; Broadbear J; Lee KO; Woods JH J Pharmacol Exp Ther; 1998 Aug; 286(2):697-703. PubMed ID: 9694923 [TBL] [Abstract][Full Text] [Related]
29. Effect of the cannabinoid receptor ligand, WIN 55,212-2, on superoxide anion and TNF-alpha production by human mononuclear cells. Germain N; Boichot E; Advenier C; Berdyshev EV; Lagente V Int Immunopharmacol; 2002 Mar; 2(4):537-43. PubMed ID: 11962732 [TBL] [Abstract][Full Text] [Related]
30. Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain. Kathmann M; Bauer U; Schlicker E; Göthert M Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):466-70. PubMed ID: 10431757 [TBL] [Abstract][Full Text] [Related]
31. In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum. Croci T; Manara L; Aureggi G; Guagnini F; Rinaldi-Carmona M; Maffrand JP; Le Fur G; Mukenge S; Ferla G Br J Pharmacol; 1998 Dec; 125(7):1393-5. PubMed ID: 9884065 [TBL] [Abstract][Full Text] [Related]
32. Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice. Kathmann M; Weber B; Schlicker E Naunyn Schmiedebergs Arch Pharmacol; 2001 Jan; 363(1):50-6. PubMed ID: 11191836 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of small intestinal secretion by cannabinoids is CB1 receptor-mediated in rats. Tyler K; Hillard CJ; Greenwood-Van Meerveld B Eur J Pharmacol; 2000 Dec; 409(2):207-11. PubMed ID: 11104836 [TBL] [Abstract][Full Text] [Related]
34. Effects of cannabinoids on colonic muscle contractility and tension in guinea pigs. Harada N; Nemoto K; Okamura T; Ninomiya N; Suzuki H; Yamamoto Y J Nippon Med Sch; 2005 Feb; 72(1):43-51. PubMed ID: 15834207 [TBL] [Abstract][Full Text] [Related]
35. Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon. Storr M; Sibaev A; Marsicano G; Lutz B; Schusdziarra V; Timmermans JP; Allescher HD Am J Physiol Gastrointest Liver Physiol; 2004 Jan; 286(1):G110-7. PubMed ID: 12893627 [TBL] [Abstract][Full Text] [Related]
36. Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats. Fattore L; Spano S; Cossu G; Deiana S; Fadda P; Fratta W Neuropharmacology; 2005 Jun; 48(8):1097-104. PubMed ID: 15910886 [TBL] [Abstract][Full Text] [Related]
37. Inhibitory effect of cannabinoid agonists on gastric emptying in the rat. Izzo AA; Mascolo N; Capasso R; Germanò MP; De Pasquale R; Capasso F Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):221-3. PubMed ID: 10494894 [TBL] [Abstract][Full Text] [Related]
38. The cannabinoid receptor agonist, WIN 55,212-2, inhibits cool-specific lamina I medullary dorsal horn neurons. Ogawa A; Meng ID Neuroscience; 2006 Nov; 143(1):265-72. PubMed ID: 16949215 [TBL] [Abstract][Full Text] [Related]
39. Large receptor reserve for cannabinoid actions in the central nervous system. Gifford AN; Bruneus M; Gatley SJ; Lan R; Makriyannis A; Volkow ND J Pharmacol Exp Ther; 1999 Feb; 288(2):478-83. PubMed ID: 9918548 [TBL] [Abstract][Full Text] [Related]